Our findings of a strong EphA2 upregulation in primary fallopian tube epithelial cells suggests that targeting EphA2 and probably other Eph receptors or its co-receptors could offer a tool to control Chlamydia-induced ovarian cancer. Here, EPHA2 is linked to ovarian cancer.